Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
Exclusive license from AstraZeneca adds a unique candidate and a broad library of compounds to Ovid’s franchise of potential first-in-class...
News
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of...
Emergent BioSolutions to Participate in Investor Conferences
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s...
Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the...
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT...
Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA
GENEVA, SWITZERLAND / ACCESSWIRE / January 3, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
Greenfield Twin Born at Midnight at Natividad is Monterey County’s First Birth of 2022
Big Brother Born 15 Minutes Earlier in 2021 Twin Born at Midnight at Natividad is Monterey County’s First Birth of...
CardioComm Solutions Enters Loan Agreement
Toronto, Ontario--(Newsfile Corp. - December 31, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical...
West Island Brands Issues Options
Toronto, Ontario--(Newsfile Corp. - December 31, 2021) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"...
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application
ORLANDO, FL / ACCESSWIRE / December 31, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the Korean Intellectual Property Office...
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement
– Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – – Together...
Nuvectis Pharma Initiates Phase 1 Clinical Trial of NXP800
The Phase 1 Study Will be Comprised of Two Parts: Phase 1a Dose-escalation that will Evaluate the Safety and Tolerability...
Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles
DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable...
Pipeline Update on gRAD Tests
December 31, 2021News release Pipeline Update on gRAD Tests BioPorto A/S (BioPorto) is supporting Rigshospitalet (RH), Copenhagen, with quantitative thrombomodulin...
USA Cystic Fibrosis Management – AirPhysio OPEP Breathing Device Store Expanded
Life Wellness Healthcare has expanded its online store to cater for new demand from customers with cystic fibrosis. The popular...
MedMira Reports First Quarter Results FY2022
HALIFAX, Nova Scotia, Dec. 30, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results...
Quipt Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
CINCINNATI, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based...
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease
Key Points: Meeting held with the US Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) to...
Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation
Mission Viejo, California, United States, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC announced today filing of a patent application...